Donald Trump’s proposed 200 per cent tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
Donald Trump’s proposed 200 per cent tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
[T]he fraternal interaction among fans from dozens of countries and the local public reminded us that isolationism is not the dominant sentiment among 349 million Americans.
[T]his blacklist has long since superseded its original military-related purpose and is now Washington’s means of tracking and suppressing China’s top enterprises.